GlassScriptPhysician profile
Richard J Murphy
NPI 1861414286
$8,658.59
in general payments reported to CMS, 2019-2025
27 companies · $1,352 in 2025
The $1,352 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $777 · 2020: $1,549 · 2021: $922 · 2022: $1,479 · 2023: $1,387 · 2024: $1,192 · 2025: $1,352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,931.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,285.71 | 2019-2025 | |
| Leo Pharma INC. | $759.81 | 2019-2025 | Adbry, Anzupgo |
| Genzyme Corporation | $746.87 | 2019-2025 | |
| Amgen INC. | $427.89 | 2019-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $426.12 | 2019-2025 | Tremfya |
| Pfizer INC. | $413.24 | 2019-2025 | |
| Incyte Corporation | $268.79 | 2022-2024 | Opzelura |
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.22 | 2022-2025 | Spevigo |
| Novartis Pharmaceuticals Corporation | $148.10 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $144.03 | 2021-2023 | Libtayo |
| Genentech USA, INC. | $143.05 | 2019 | |
| Janssen Scientific Affairs, LLC | $125.00 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $113.82 | 2022-2024 | Sotyktu |
| Journey Medical Corporation | $83.62 | 2020-2021 | |
| Lilly USA, LLC | $80.43 | 2019-2024 | Olumiant, Taltz |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $63.00 | 2022-2024 | Bimzelx |
| Dermavant Sciences, INC. | $62.97 | 2023 | Vtama |
| Sun Pharmaceutical Industries INC. | $43.90 | 2022-2023 | Absorica Ld, Winlevi |
| Verrica Pharmaceuticals INC. | $33.12 | 2024 | Ycanth |
| Kyowa Kirin, INC. | $24.30 | 2022 | |
| Organon LLC | $21.63 | 2025 | Vtama |
| Baudax Bio INC. | $19.54 | 2020 | |
| Celgene Corporation | $19.35 | 2019 | |
| Dusa Pharmaceuticals, INC. | $16.73 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.19 | 2019 | |
| Nabriva Therapeutics, Plc | $13.84 | 2022 | |
| Prugen, INC. Pharmaceuticals | $8.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.